Targeting INF2 with DiosMetin 7-O-beta-D-Glucuronide: a new stratagem for colorectal cancer therapy. Zeng Z, Ke Y, Huang F, Li H, et al. BMC Cancer 2025;25:982.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zeng Z, Ke Y, Huang F, Li H, et al. Targeting INF2 with DiosMetin 7-O-beta-D-Glucuronide: a new stratagem for colorectal cancer therapy. BMC Cancer 2025;25:982.
PMID: 40452021